InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 40258

Sunday, 06/20/2021 11:49:26 AM

Sunday, June 20, 2021 11:49:26 AM

Post# of 44690
Recent evidence indicates that vasoactive intestinal peptide (VIP), an anti-inflammatory neuropeptide with therapeutic potential in various immune disorders, participates in maintaining immune tolerance by a novel mechanism of inducing the generation of Treg cells.

https://www.cell.com/trends/molecular-medicine/comments/S1471-4914(07)00067-6

WILL VIP BECOME THE STANDARD OF CARE IN IMMUNOTHERAPY???